Elliot Stieglitz
- University of California, San Francisco · Pediatrics (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #15,738
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11634865Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-7032-4623Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pediatrics
NIH Funding · FY2026
Linked Award Amount
$1.3M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#15,738
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Elliot Stieglitz as a PI. Multi-PI records show the full award amount for context.
- 5R37CA266550-05R37Contact PIImplementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.University of California, San Francisco · Pediatrics (NIH department code)$675.6Kaward amount
- 1R01CA316529-01R01Contact PIInvestigating the Determinants of Response to Pan-RAS Inhibition in Juvenile Myelomonocytic LeukemiaUniversity of California, San Francisco · Pediatrics (NIH department code)$587.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Elliot Stieglitz as a PI.
FY2026 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of California, San Francisco
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding